Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 7, 2023
August 4, 2023
6238372e-b9bf-421b-9c22-eda707398371
Related Documents
Reformulating Drug Products That Contain Carbomers Manufactured With Benzene
Guidance DocumentDecember 28, 2023Center for Drug Evaluation and Research
COVID-19: Developing Drugs and Biological Products for Treatment or Prevention: Guidance for Industry
Guidance DocumentNovember 24, 2023Center for Drug Evaluation and Research
Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization
Guidance DocumentDecember 21, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.